Makiej Aleksandra, Smułek Wojciech, Dubrowska Kamila, Augustyniak Adrian, Bernat Przemysław, Kaczorek Ewa
Institute of Chemical Technology and Engineering, Faculty of Chemical Technology, Poznan University of Technology, Berdychowo 4, Poznan 60-965, Poland.
Department of Chemical and Process Engineering, Faculty of Chemical Technology and Engineering, West Pomeranian University of Technology, Piastów Avenue 42, Szczecin 71-065, Poland.
ACS Omega. 2025 Aug 25;10(35):39658-39668. doi: 10.1021/acsomega.5c03035. eCollection 2025 Sep 9.
Bacterial infections remain a significant health concern, necessitating the continuous exploration of novel therapeutic strategies. extract, renowned for its bioactive saponins, presents a promising approach for combating bacterial pathogens. This study investigates the potential of extract (SM) as a bioenhancer for the polymyxin B antibiotic (PMB) against four bacterial strains: (SA), (SE), (PA), and (EC). Research methods were used to determine the metabolic activity of the strains and the changes in their cell membrane permeability. Furthermore, advanced microscopic techniques (confocal and transmission electron microscopy) were used to confirm the viability and visualize morphological changes within selected strains. Obtained data were also correlated with the lipidomic and fatty acid methyl ester profiles of strains subjected to the described treatments. Results indicated that the conjugated treatment of bacterial cells with PMB and SM extract demonstrated an enhancement of bacterial total membrane permeability in comparison to the treatment with PMB alone. Notably, for the strain, a significant decrease in viability was noted, which can be associated with the significant (in terms of statistical analysis) increase in cell membrane permeability for cells treated with SM and PMB, compared with samples treated with PMB alone. This was further conjoined and proven by the results of the FAME and lipidomic analyses. Specifically for , an increase in branched fatty acids was detected in cells exposed to SM and SM + PMB. Additionally, the lipidomic analysis revealed notable membrane remodeling, characterized by an increase in lysyl-phosphatidylglycerol and diglucosyldiglyceride and a decrease in phosphatidylglycerol, in samples treated with SM and SM + PMB compared to the control group. This study underscores the potential of extract as an enhancing agent to PMB in combination therapies against bacterial infections, paving the way for further investigations into its mechanistic insights and clinical applications.
细菌感染仍然是一个重大的健康问题,因此需要不断探索新的治疗策略。以其生物活性皂苷而闻名的提取物,为对抗细菌病原体提供了一种有前景的方法。本研究调查了提取物(SM)作为多粘菌素B抗生素(PMB)针对四种细菌菌株的生物增强剂的潜力:金黄色葡萄球菌(SA)、表皮葡萄球菌(SE)、铜绿假单胞菌(PA)和大肠杆菌(EC)。采用研究方法来确定菌株的代谢活性及其细胞膜通透性的变化。此外,还使用了先进的显微镜技术(共聚焦和透射电子显微镜)来确认所选菌株的活力并可视化其形态变化。获得的数据还与接受所述处理的菌株的脂质组学和脂肪酸甲酯谱相关联。结果表明,与单独使用PMB处理相比,用PMB和SM提取物联合处理细菌细胞显示出细菌总膜通透性增强。值得注意的是,对于金黄色葡萄球菌菌株,观察到活力显著下降,这可能与用SM和PMB处理的细胞相比单独用PMB处理的样品在细胞膜通透性方面的显著(从统计分析角度)增加有关。这一点通过脂肪酸甲酯和脂质组学分析的结果进一步得到证实和关联。具体对于金黄色葡萄球菌,在暴露于SM和SM + PMB的细胞中检测到支链脂肪酸增加。此外,脂质组学分析显示,与对照组相比,用SM和SM + PMB处理的样品中存在明显的膜重塑,其特征是赖氨酰磷脂酰甘油和二葡萄糖二甘油酯增加,磷脂酰甘油减少。本研究强调了提取物作为PMB在联合治疗细菌感染中的增强剂的潜力,为进一步研究其作用机制和临床应用铺平了道路。